» Articles » PMID: 39456775

The Association and Prognostic Implications of Long Non-Coding RNAs in Major Psychiatric Disorders, Alzheimer's Diseases and Parkinson's Diseases: A Systematic Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 26
PMID 39456775
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of psychiatric disorders and neurodegenerative diseases is steadily increasing, placing a significant burden on both society and individuals. Given the intricate and multifaceted nature of these diseases, the precise underlying mechanisms remain elusive. Consequently, there is an increasing imperative to investigate the mechanisms, identify specific target sites for effective treatment, and provide for accurate diagnosis of patients with these diseases. Numerous studies have revealed significant alterations in the expression of long non-coding RNAs (lncRNAs) in psychiatric disorders and neurodegenerative diseases, suggesting their potential to increase the probability of these diseases. Moreover, these findings propose that lncRNAs could be used as highly valuable biomarkers in diagnosing and treating these diseases, thereby offering novel insights for future clinical interventions. The review presents a comprehensive summary of the origin, biological functions, and action mechanisms of lncRNAs, while exploring their implications in the pathogenesis of psychiatric disorders and neurodegenerative diseases and their potential utility as biomarkers.

References
1.
Pompili M, Innamorati M, Raja M, Falcone I, Ducci G, Angeletti G . Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?. Neuropsychiatr Dis Treat. 2008; 4(1):247-55. PMC: 2515901. DOI: 10.2147/ndt.s2192. View

2.
Hu J, Xu J, Pang L, Zhao H, Li F, Deng Y . Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis. Oncotarget. 2016; 7(44):71087-71098. PMC: 5342065. DOI: 10.18632/oncotarget.12122. View

3.
Teng P, Li Y, Ku L, Wang F, Goldsmith D, Wen Z . The human lncRNA GOMAFU suppresses neuronal interferon response pathways affected in neuropsychiatric diseases. Brain Behav Immun. 2023; 112:175-187. PMC: 10527610. DOI: 10.1016/j.bbi.2023.06.009. View

4.
Joshi N, Singh S . Updates on immunity and inflammation in Parkinson disease pathology. J Neurosci Res. 2017; 96(3):379-390. DOI: 10.1002/jnr.24185. View

5.
Qi P, Du X . The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2012; 26(2):155-65. DOI: 10.1038/modpathol.2012.160. View